Leukemia Under the Lens, 1845

Alfred Donné’s microscopic daguerreotypes described the cellular symptoms of leukemia for the first time.

Written byJenny Rood
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

OF BLOOD AND PUS: Alfred Donné’s microscopic views of bodily fluids, published in the supplement to Cours de Microscopie in 1845, allowed for a clearer distinction between white blood cells and pus, which were often confused by Donné’s contemporaries. Such investigations provided a clue to the origins of leukemia as a disease. A) Red and white blood cells from a leukemic patient; B) and C) “mucous globules,” or white blood cells, from the same patient; D) mucous globules treated with acetic acid to visualize nuclei; E) recently secreted pus globules from a different patient; F) pus globules treated with acetic acid to visualize nuclei. COURTESY KIM KAMPENIn 1837, over the objections of skeptical colleagues, Alfred François Donné set up 20 microscopes at his own expense in the lecture hall of the Medical Faculty of Paris. There, he provided practical microscopy lessons to students. His goal was to make microscopy a standard part of medical practice, an aim he had already championed with the invention of a foldable pocket microscope.

When Louis Daguerre presented his brand-new photographic technique in 1839, Donné leapt at the chance to modify it to capture his microscopic images to spice up his lectures to ever-growing audiences. Donné’s adoption of such cutting-edge technology established him as a pioneer in the use of photographs—rather than hand-drawn sketches—to communicate scientific discoveries.

One of Donné’s students, John Hughes Bennett, only briefly attended the Frenchman’s microscopy course in 1841, but four years later would credit Donné’s enthusiasm for inspiring his own microscopic investigation of a patient with an enlarged spleen and liver. In the patient’s blood, Bennett found a large number of “colorless corpuscles,” or white blood cells. He named the disease leucocythemia, a condition we now know as leukemia.

A case describing leukemia-like symptoms ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies